<SEC-DOCUMENT>0000784199-18-000137.txt : 20180620
<SEC-HEADER>0000784199-18-000137.hdr.sgml : 20180620
<ACCEPTANCE-DATETIME>20180620072224
ACCESSION NUMBER:		0000784199-18-000137
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20180620
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20180620
DATE AS OF CHANGE:		20180620

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CRYOLIFE INC
		CENTRAL INDEX KEY:			0000784199
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				592417093
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13165
		FILM NUMBER:		18908653

	BUSINESS ADDRESS:	
		STREET 1:		1655 ROBERTS BOULEVARD N W
		CITY:			KENNESAW
		STATE:			GA
		ZIP:			30144
		BUSINESS PHONE:		7704193355

	MAIL ADDRESS:	
		STREET 1:		1655 ROBERTS BOULEVARD N W
		CITY:			KENNESAW
		STATE:			GA
		ZIP:			30144
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>c199-20180620x8k.htm
<DESCRIPTION>8-K
<TEXT>
<!--HTML document created with Certent Disclosure Management 6.18.0.1-->
<!--Created on: 6/20/2018 7:20:28 AM-->
<html>
	<head>
		<title>
			20180619 8K Borgstrom
		</title>
	</head>
	<body><div style="margin-left:72pt;margin-right:72pt;">
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:478.80pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt">
						<a name="_GoBack"></a><font style="display: inline;font-size:1pt;">&#xFEFF;</font><a name="_DV_M0"></a></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:478.80pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;">&#xFEFF;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-size:11pt;">UNITED STATES</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
			<a name="_DV_M1"></a><font style="display: inline;font-weight:bold;font-size:11pt;">SECURITIES AND EXCHANGE COMMISSION</font><br /><font style="display: inline;font-weight:bold;font-size:11pt;"></font><font style="display: inline;font-weight:bold;font-size:11pt;">Washington, D.C. 20549</font><br /><font style="display: inline;font-weight:bold;font-size:11pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
			<a name="_DV_M2"></a><font style="display: inline;font-weight:bold;font-size:11pt;">FORM 8-K</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-size:11pt;">CURRENT REPORT</font><br /><font style="display: inline;font-weight:bold;font-size:11pt;">PURSUANT TO SECTION 13 OR 15(d) OF THE</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
			<a name="_DV_M3"></a><font style="display: inline;font-weight:bold;font-size:11pt;">SECURITIES EXCHANGE ACT OF 1934</font><br /><font style="display: inline;font-weight:bold;font-size:11pt;"></font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-size:11pt;">Date of Report (Date of ear</font><font style="display: inline;font-weight:bold;font-size:11pt;">liest event reported): </font><font style="display: inline;font-weight:bold;font-size:11pt;">June 19, 2018</font><br /><font style="display: inline;font-weight:bold;font-size:11pt;"></font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
			<a name="_DV_M5"></a><font style="display: inline;font-weight:bold;font-size:11pt;">_______________________</font><br /><font style="display: inline;font-weight:bold;font-size:11pt;"></font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
			<a name="_DV_M6"></a><font style="display: inline;font-weight:bold;font-size:11pt;">CRYOLIFE, INC.</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
			<a name="_DV_M7"></a><font style="display: inline;font-size:11pt;">(Exact name of registrant as specified in its charter)</font><br /><font style="display: inline;font-weight:bold;font-size:11pt;">_________________________</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-size:11pt;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:159.60pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-weight:bold;font-size:11pt;">Florida</font></p>
				</td>
				<td valign="top" style="width:159.60pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-weight:bold;font-size:11pt;">1-13165</font></p>
				</td>
				<td valign="top" style="width:159.60pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-weight:bold;font-size:11pt;">59-2417093</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:159.60pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">(State or Other Jurisdiction</font><br /><font style="display: inline;font-size:11pt;">of Incorporation)</font></p>
				</td>
				<td valign="top" style="width:159.60pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">(Commission File Number)</font></p>
				</td>
				<td valign="top" style="width:159.60pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">(IRS Employer</font></p>
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">Identification No.)</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
			<a name="_DV_M8"></a><font style="display: inline;font-weight:bold;font-size:11pt;">1655 Roberts Boulevard, N.W., Kennesaw, Georgia&nbsp;&nbsp;30144</font><br /><font style="display: inline;font-size:11pt;">(Address of principal executive office) (zip code)</font><br /><font style="display: inline;font-size:11pt;"></font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
			<a name="_DV_M9"></a><font style="display: inline;font-weight:bold;font-size:11pt;">Registrant's telephone number, including area code: (770) 419-3355</font><br /><font style="display: inline;font-weight:bold;font-size:11pt;"></font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
			<a name="_DV_M10"></a><font style="display: inline;font-size:10pt;">_____________________________________________________________</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
			<a name="_DV_M11"></a><font style="display: inline;font-size:10pt;">(Former name or former address, if changed since last report)</font><br /><font style="display: inline;font-size:10pt;"></font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
			<a name="_DV_M12"></a><font style="display: inline;font-weight:bold;font-size:10pt;">_________________________</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<a name="_DV_M13"></a><font style="display: inline;font-size:10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 18pt;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#x2610;</font><a name="_DV_M14"></a><font style="display: inline;font-size:10pt;font-family:Wingdings;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 18pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font>
		</p>
		<p style="margin:0pt 0pt 0pt 18pt;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 18pt;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<a name="_DV_M15"></a><font style="display: inline;font-size:10pt;">&#x2610;</font><font style="display: inline;font-size:10pt;font-family:Wingdings;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 18pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font>
		</p>
		<p style="margin:0pt 0pt 0pt 18pt;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 6pt 18pt;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<a name="_DV_M16"></a><font style="display: inline;font-size:10pt;">&#x2610;</font><font style="display: inline;font-size:10pt;font-family:Wingdings;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 18pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font>
		</p>
		<p style="margin:0pt 0pt 0pt 18pt;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#x2610;</font><a name="_DV_M17"></a><font style="display: inline;font-size:10pt;font-family:Wingdings;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 18pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font>
		</p>
		<p style="margin:12pt 0pt 6pt;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#xA7;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#xA7;240.12b-2 of this chapter). </font>
		</p>
		<p style="margin:12pt 0pt 6pt;border-top:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">Emerging growth company </font><font style="display: inline;color:#000000;font-size:10pt;">&#x2610;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 18pt;line-height:13pt;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</font><font style="display: inline;font-family:74flzqmmzksgovw;font-size:10pt;">&nbsp;</font><font style="display: inline;color:#000000;font-size:10pt;">&#x2610;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			&nbsp;
		</p></div><div style="margin-left:72pt;margin-right:72pt;">
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;font-family:CG Omega;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;color:#000000;">&#xFEFF;</font><a name="_DV_M18"></a><a name="_DV_M19"></a><a name="_DV_M20"></a>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:63.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;">Section 5</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:414.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;color:#000000;">Corp. Governance and Management</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:63.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:414.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:63.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;">Item 5.02</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:414.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;color:#000000;">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-weight:bold;color:#000000;"></font><font style="display: inline;color:#000000;">On </font><font style="display: inline;color:#000000;">June</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">1</font><font style="display: inline;color:#000000;">9</font><font style="display: inline;color:#000000;">, 201</font><font style="display: inline;color:#000000;">8</font><font style="display: inline;color:#000000;">, the Board of Directors (the &#x201C;Board&#x201D;) of CryoLife, Inc. a Florida corporation (NYSE: CRY) (the &#x201C;Company&#x201D;) increased the size of the Company&#x2019;s Board to nine members and elected </font><font style="display: inline;color:#000000;">Marna P. Borgstrom</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">as a director of the Company. M</font><font style="display: inline;color:#000000;">s</font><font style="display: inline;color:#000000;">. &nbsp;</font><font style="display: inline;color:#000000;">B</font><font style="display: inline;color:#000000;">orgstrom</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">will be included </font><font style="display: inline;color:#000000;">as one of</font><font style="display: inline;color:#000000;"> the Company&#x2019;s directors who will stand for reelection by the Company&#x2019;s shareholders at the Company&#x2019;s Annual Meeting to be held in May 201</font><font style="display: inline;color:#000000;">9</font><font style="display: inline;color:#000000;">. On </font><font style="display: inline;color:#000000;">June 19</font><font style="display: inline;color:#000000;">, 201</font><font style="display: inline;color:#000000;">8</font><font style="display: inline;color:#000000;">,</font><font style="display: inline;color:#000000;"> the Company issued a press release regarding M</font><font style="display: inline;color:#000000;">s</font><font style="display: inline;color:#000000;">. &nbsp;</font><font style="display: inline;color:#000000;">B</font><font style="display: inline;color:#000000;">orgstrom</font><font style="display: inline;color:#000000;">&#x2019;s </font><font style="display: inline;color:#000000;">appointment, a copy of which is attached hereto. </font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;color:#000000;">The Board has affirmatively determined th</font><font style="display: inline;color:#000000;">at</font><font style="display: inline;color:#000000;"> &nbsp;M</font><font style="display: inline;color:#000000;">s</font><font style="display: inline;color:#000000;">. &nbsp;</font><font style="display: inline;color:#000000;">B</font><font style="display: inline;color:#000000;">orgstrom</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">qualifies </font><font style="display: inline;color:#000000;">as an independent director under the categorical standards of the corporate governance rules of New York Stock Exchange as defined under applicable law. </font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">There are no arrangements or understandings between M</font><font style="display: inline;color:#000000;">s</font><font style="display: inline;color:#000000;">. &nbsp;</font><font style="display: inline;color:#000000;">B</font><font style="display: inline;color:#000000;">orgstrom</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">and any person pursuant to </font><font style="display: inline;color:#000000;">which M</font><font style="display: inline;color:#000000;">s</font><font style="display: inline;color:#000000;">. &nbsp;</font><font style="display: inline;color:#000000;">B</font><font style="display: inline;color:#000000;">orgstrom</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">was selected as a director, and there are no actual or proposed transactions between M</font><font style="display: inline;color:#000000;">s</font><font style="display: inline;color:#000000;">. &nbsp;</font><font style="display: inline;color:#000000;">B</font><font style="display: inline;color:#000000;">orgstrom</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">or</font><font style="display: inline;color:#000000;"> any of her</font><font style="display: inline;color:#000000;"> related persons and the Company that would require disclosure under Item 404(a) of Regulation S-K (17 CFR 22</font><font style="display: inline;color:#000000;">9.404(a)) in connection with her</font><font style="display: inline;color:#000000;"> appointment as a director of the Company.</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">As of the date of her appointment, Ms</font><font style="display: inline;color:#000000;">. &nbsp;</font><font style="display: inline;color:#000000;">B</font><font style="display: inline;color:#000000;">orgstrom</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">is entitled to receive compensation and participate in the plans of the Company applicable to all of the Company&#x2019;s directors, as more particularly described on </font><font style="display: inline;color:#000000;">page</font><font style="display: inline;color:#000000;"> &nbsp;1</font><font style="display: inline;color:#000000;">9</font><font style="display: inline;color:#000000;"> of the Comp</font><font style="display: inline;color:#000000;">any&#x2019;s proxy statement filed </font><font style="display: inline;color:#000000;">April 3</font><font style="display: inline;color:#000000;">, 201</font><font style="display: inline;color:#000000;">8</font><font style="display: inline;color:#000000;">, under th</font><font style="display: inline;color:#000000;">e sub-heading &#x201C;Elements of Non-Employee Director Compensation</font><font style="display: inline;color:#000000;">&#x201D;</font><font style="display: inline;color:#000000;">. In accordance with such plans, </font><font style="display: inline;color:#000000;">M</font><font style="display: inline;color:#000000;">s</font><font style="display: inline;color:#000000;">. &nbsp;</font><font style="display: inline;color:#000000;">B</font><font style="display: inline;color:#000000;">orgstrom</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">will be</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">granted,</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">as soon as practicable after any applicable trading blackout has been lifted, </font><font style="display: inline;color:#000000;">a restricted stock award value</font><font style="display: inline;color:#000000;">d at $</font><font style="display: inline;color:#000000;">114</font><font style="display: inline;color:#000000;">,</font><font style="display: inline;color:#000000;">583</font><font style="display: inline;color:#000000;"> on the grant date</font><font style="display: inline;color:#000000;">, such award to vest </font><font style="display: inline;color:#000000;">one year front grant</font><font style="display: inline;color:#000000;">.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">I</font><font style="display: inline;color:#000000;">n addition</font><font style="display: inline;color:#000000;">,</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">commencing on </font><font style="display: inline;color:#000000;">July</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">1, 201</font><font style="display: inline;color:#000000;">8</font><font style="display: inline;color:#000000;">, M</font><font style="display: inline;color:#000000;">s</font><font style="display: inline;color:#000000;">.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">B</font><font style="display: inline;color:#000000;">orgstrom</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">will receive monthly cash compensation for </font><font style="display: inline;color:#000000;">her</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">service on the Board ($3,</font><font style="display: inline;color:#000000;">750</font><font style="display: inline;color:#000000;">/month) </font><font style="display: inline;color:#000000;">and </font><font style="display: inline;color:#000000;">for h</font><font style="display: inline;color:#000000;">er</font><font style="display: inline;color:#000000;"> ser</font><font style="display: inline;color:#000000;">vice on the Compliance</font><font style="display: inline;color:#000000;"> Committee </font><font style="display: inline;color:#000000;">($</font><font style="display: inline;color:#000000;">416.66</font><font style="display: inline;color:#000000;">/</font><font style="display: inline;color:#000000;">month</font><font style="display: inline;color:#000000;">) &nbsp;</font><font style="display: inline;color:#000000;">until such time as the Company&#x2019;s </font><font style="display: inline;color:#000000;">Board</font><font style="display: inline;color:#000000;"> determine</font><font style="display: inline;color:#000000;">s</font><font style="display: inline;color:#000000;"> to modify the cash component for director compensation</font><font style="display: inline;color:#000000;"> or committee membership</font><font style="display: inline;color:#000000;"> or M</font><font style="display: inline;color:#000000;">s</font><font style="display: inline;color:#000000;">. &nbsp;</font><font style="display: inline;color:#000000;">B</font><font style="display: inline;color:#000000;">orgstrom</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">ceases to be a director</font><font style="display: inline;color:#000000;"> or to serve on the C</font><font style="display: inline;color:#000000;">ompliance</font><font style="display: inline;color:#000000;"> Committee</font><font style="display: inline;color:#000000;">. Each of the foregoing awards was made in respect of, and prorated to, M</font><font style="display: inline;color:#000000;">s</font><font style="display: inline;color:#000000;">. &nbsp;</font><font style="display: inline;color:#000000;">B</font><font style="display: inline;color:#000000;">orgstrom</font><font style="display: inline;color:#000000;">&#x2019;s </font><font style="display: inline;color:#000000;">service from the date of her</font><font style="display: inline;color:#000000;"> appointment until the anticipated date of the Company&#x2019;s next Annual Meeting. </font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">Except as set forth above, there is no other material Company plan, contract or arrangement in which M</font><font style="display: inline;color:#000000;">s</font><font style="display: inline;color:#000000;">. &nbsp;</font><font style="display: inline;color:#000000;">Borgstrom</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">will pa</font><font style="display: inline;color:#000000;">rticipate in connection with her</font><font style="display: inline;color:#000000;"> appointment. </font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;color:#000000;"></font><font style="display: inline;color:#000000;"> &nbsp; &nbsp;</font><font style="display: inline;color:#000000;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;font-family:CG Omega;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;color:#000000;"></font><font style="display: inline;font-weight:bold;">Section 9</font><font style="display: inline;font-weight:bold;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-weight:bold;">Financial Statements and Exhibits.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">Item 9.01(d)</font><font style="display: inline;font-weight:bold;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-weight:bold;">Exhibits</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">(a)</font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;">Financial Statements</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;">Not applicable</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">(b)</font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;">Pro Forma Financial Information.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;">Not applicable.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">(c)</font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;">Shell Company Transactions.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;">Not applicable.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">(d)</font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;">Exhibits.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:117.90pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt">
						<font style="display: inline;font-size:1pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:117.90pt;border-bottom:1pt solid #000000 ;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">Exhibit Number</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:239.40pt;border-bottom:1pt solid #000000 ;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">Description</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:117.90pt;border-top:1pt solid #000000 ;border-bottom:1pt solid #000000 ;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&#xFEFF;</font><a href="c199-20180620xex99_1.htm" style="-sec-extract:exhibit"><font style="display: inline;">99.1</font></a><font style="display: inline;">*</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:239.40pt;border-top:1pt solid #000000 ;border-bottom:1pt solid #000000 ;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">Press release dated </font><font style="display: inline;">June 19, 2018</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">*This exhibit is furnished, not filed.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">&#xFEFF;</font><a name="_DV_M30"></a><a name="_DV_M38"></a>
		</p>
		<p style="margin:0pt 0pt 0pt 144pt;text-indent: -108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;font-family:CG Omega;font-size: 12pt">

			&nbsp;

		</p>

		<p style="margin:0pt;font-family:CG Omega;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;font-weight:bold;"></font><font style="display: inline;font-weight:bold;">SIGNATURES</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_DV_M39"></a><br /><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;">Pursuant to the requirements of the Securities Exchange Act of 1934, CryoLife, Inc. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:221.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&#xFEFF;</font></p>
				</td>
				<td colspan="2" valign="top" style="width:257.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">CRYOLIFE, INC.</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:221.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&#xFEFF;</font></p>
				</td>
				<td colspan="2" valign="top" style="width:257.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:221.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&#xFEFF;</font></p>
				</td>
				<td colspan="2" valign="top" style="width:257.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:221.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">Date:&nbsp;&nbsp;June 20</font><font style="display: inline;">, 2018</font></p>
				</td>
				<td valign="top" style="width:45.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">By:</font></p>
				</td>
				<td valign="top" style="width:212.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">/s/ D. Ashley Lee</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:221.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:45.00pt;border-left:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">Name:</font></p>
				</td>
				<td valign="top" style="width:212.40pt;border-left:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">D. Ashley Lee</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:221.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:45.00pt;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">Title:</font></p>
				</td>
				<td valign="top" style="width:212.40pt;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">Executive Vice President, Chief&nbsp;&nbsp;&nbsp;&nbsp;Operating Officer and Chief Financial Officer</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;font-family:CG Omega;font-size: 12pt">

			&nbsp;

		</p>

		<p style="margin:0pt;font-family:CG Omega;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr>
	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>c199-20180620xex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!--HTML document created with Certent Disclosure Management 6.18.0.1-->
<!--Created on: 6/20/2018 7:20:33 AM-->
<html>
	<head>
		<title>
			2018.06.19 8K Borgstrom exh 99.1
		</title>
	</head>
	<body><div style="margin-left:72pt;margin-right:72pt;"><div style="width:100%">

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;font-size:11pt;">Exhibit 99.1</font>

		</p>

</div>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<a name="_GoBack"></a><font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:150%;text-align:left;text-justify:inter-ideograph;font-weight:bold;font-family:Times New Roman;font-size: 12pt">
			<a name="_DV_M0"></a><font style="display: inline;font-style:italic;font-size:12pt;">FOR IMMEDIATE RELEASE </font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
			<br /><font style="display: inline;font-weight:bold;font-size:11pt;">Contacts:</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-size:11pt;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:261.90pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden">
						<font style="display: inline;font-weight:bold;font-size:11pt;;font-size: 11pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;;font-size: 11pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;;font-size: 11pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;;font-size: 11pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:11pt;"></font><font style="display: inline;font-size:11pt;"></font></p>
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 11pt">
						<font style="display: inline;font-size:11pt;;font-size: 11pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:11pt;"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Phone: 770-419-3355</font></p>
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:210.90pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display: inline;font-size:11pt;">&nbsp;</font></p>
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:261.90pt;height:16.25pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-weight:bold;font-size:11pt;">CryoLife </font><font style="display: inline;font-weight:bold;font-size:11pt;;font-size: 11pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-weight:bold;font-size:11pt;"></font><font style="display: inline;font-weight:bold;font-size:11pt;;font-size: 11pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:11pt;"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p>
				</td>
				<td valign="top" style="width:210.90pt;height:16.25pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-weight:bold;font-size:11pt;">The Ruth Group</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:261.90pt;height:16.10pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">D. Ashley Lee</font></p>
				</td>
				<td valign="top" style="width:210.90pt;height:16.10pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">Tram Bui / Emma Poalillo</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:261.90pt;height:16.10pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">Executive Vice President, Chief Financial Officer and Chief Operating Officer</font></p>
				</td>
				<td valign="top" style="width:210.90pt;height:16.10pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">646-536-7035 / 7024</font></p>
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-size:11pt;">tbui@theruthgroup.com</font><font style="display: inline;"> &nbsp;/</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:261.90pt;height:16.10pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">Phone: 770-419-3355</font></p>
				</td>
				<td valign="top" style="width:210.90pt;height:16.10pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-size:11pt;">epoalillo@theruthgroup.com</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;border-bottom:1pt none #D9D9D9 ;text-align:center;font-family:Times New Roman;font-size: 14pt">
			<font style="font-family:Verdana;font-weight:bold;color:#000000;font-size:9pt;display: inline;font-family:Times New Roman;text-transform:none;font-size:14pt;">Marna Borgstrom </font><font style="font-family:Verdana;font-weight:bold;color:#000000;font-size:9pt;display: inline;font-family:Times New Roman;text-transform:none;font-size:14pt;">Joins CryoLife Board of Directors</font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;text-align:center;font-family:Times New Roman;font-size: 14pt">
			<font style="font-family:Verdana;font-weight:bold;color:#000000;font-size:9pt;display: inline;font-family:Times New Roman;text-transform:none;font-size:14pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_DV_M6"></a><font style="display: inline;font-weight:bold;color:#000000;">ATLANTA, GA&#x2026;(</font><font style="display: inline;font-weight:bold;color:#000000;">June </font><font style="display: inline;font-weight:bold;color:#000000;">19</font><font style="display: inline;font-weight:bold;color:#000000;">, 2018)&#x2026;CryoLife, Inc. (NYSE: CRY), </font><font style="display: inline;color:#000000;background-color: #FFFFFF;">a leading cardiac and vascular surgery company focused on aortic disease, </font><font style="display: inline;color:#000000;">today announced the </font><font style="display: inline;color:#000000;">appointment of </font><font style="display: inline;color:#000000;">Marna Borgstrom</font><font style="display: inline;color:#000000;"> to its Board of Directors effective </font><font style="display: inline;color:#000000;">immediately</font><font style="display: inline;color:#000000;">.</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">Pat Mackin, Chairman, President, and Chief Executive Officer, commented,</font><font style="display: inline;color:#000000;"> &#x201C;Marna has nearly 40 years of </font><font style="display: inline;color:#000000;">escalating </font><font style="display: inline;color:#000000;">senior leadership </font><font style="display: inline;color:#000000;">experience</font><font style="display: inline;color:#000000;"> at Yale New Haven Health System</font><font style="display: inline;color:#000000;">, where </font><font style="display: inline;color:#000000;">she was an integral part of the system&#x2019;s </font><font style="display: inline;color:#000000;">strategy and </font><font style="display: inline;color:#000000;">evolution into a multi-unit health system</font><font style="display: inline;color:#000000;"> as the current CEO</font><font style="display: inline;color:#000000;">. &nbsp;</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">Marna is</font><font style="display: inline;color:#000000;"> well</font><font style="display: inline;color:#000000;">-</font><font style="display: inline;color:#000000;">versed in driving profitability</font><font style="display: inline;color:#000000;"> while operating on a budget</font><font style="display: inline;color:#000000;"> and has deep</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">experience in developing partnerships and recruiting and retaining executives and physician leaders.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">Her extensive experience</font><font style="display: inline;color:#000000;"> coupled with her </font><font style="display: inline;color:#000000;">knowledge </font><font style="display: inline;color:#000000;">and recognition within </font><font style="display: inline;color:#000000;">the </font><font style="display: inline;color:#000000;">healthcare </font><font style="display: inline;color:#000000;">industry will </font><font style="display: inline;color:#000000;">complement</font><font style="display: inline;color:#000000;"> our Board and provide invaluable guidance as we continue our mission as a market leader.&#x201D;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">Ms. Borgstrom stated, &#x201C;</font><font style="display: inline;">I &nbsp;</font><font style="display: inline;">appreciate the opportunity </font><font style="display: inline;">to join the CryoLife Board of Directors, as I see </font><font style="display: inline;">the Company&#x2019;s unwavering commitment to the advancement of patient </font><font style="display: inline;">standard of care</font><font style="display: inline;"> and quality of life matched only by my own. </font><font style="display: inline;">&nbsp;</font><font style="display: inline;">I look forward to working with </font><font style="display: inline;">the </font><font style="display: inline;">CryoLife</font><font style="display: inline;"> team as they continue to </font><font style="display: inline;">drive the Company&#x2019;s growth and industry awareness</font><font style="display: inline;">.&#x201D;&nbsp;&nbsp; </font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">Since 2005, </font><font style="display: inline;color:#000000;">Ms. Borgstrom </font><font style="display: inline;color:#000000;">has presided as </font><font style="display: inline;color:#000000;">President and C</font><font style="display: inline;color:#000000;">hief </font><font style="display: inline;color:#000000;">E</font><font style="display: inline;color:#000000;">xecutive </font><font style="display: inline;color:#000000;">O</font><font style="display: inline;color:#000000;">fficer</font><font style="display: inline;color:#000000;"> in addition to a board member</font><font style="display: inline;color:#000000;"> of the Yale New Haven Health System,</font><font style="display: inline;color:#000000;"> an integrated health care delivery system</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">that operates in Connecticut, western Rhode Island and Westchester County (New York)</font><font style="display: inline;color:#000000;">.&nbsp; </font><font style="display: inline;color:#000000;">Additionally, Ms. Borgstrom </font><font style="display: inline;color:#000000;">currently </font><font style="display: inline;color:#000000;">serves </font><font style="display: inline;color:#000000;">on several </font><font style="display: inline;color:#000000;">nationally recognized boards</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">including</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">Vizient, </font><font style="display: inline;color:#000000;">Inc.,</font><font style="display: inline;color:#000000;"> a privately held, member-driven health care performance improvement company,</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">the Coalition to Protect America&#x2019;s Healthcare and the Healthcare Institute</font><font style="display: inline;color:#000000;">.&nbsp; </font><font style="display: inline;">Ms. Borgstrom received her Bachelor of Arts from Stanford University and </font><font style="display: inline;">Masters in Public Health from Yale University</font><font style="display: inline;">. &nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p>
		<p style="margin:0pt;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;color:#000000;"></font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-weight:bold;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;font-size:12pt;">About CryoLife</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair.&nbsp;&nbsp;CryoLife markets and sells products in more than 90 countries worldwide.&nbsp;&nbsp;For additional information about CryoLife, visit our website, </font><font style="display: inline;">www.cryolife.com</font><font style="display: inline;color:#000000;">.&nbsp; </font>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt">

			<font style="display: inline;font-size:10pt;">Page </font><font style="display: inline;font-size:10pt;"></font><font style="display: inline;font-size:10pt;">2</font><font style="display: inline;font-size:10pt;"></font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr>
	</div></body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
